Prime Minister Justin Trudeau announced on Tuesday that Canada has signed a tentative agreement for Novavax to produce millions of doses of its COVID-19 vaccine in Canada once it’s approved for use.
The U.S. company is still doing clinical trials of its vaccine, but if Health Canada approves it, a new National Research Council facility in Montreal will begin producing Novavax doses when the building is finished later this year. It would be the first COVID-19 vaccine to be produced domestically.
Canada is currently at the mercy of foreign governments, which could at any time slam the doors shut to vaccine exports until their own people are vaccinated. That risk becomes ever more real this week as Europe’s new export controls on vaccines take hold, putting at risk Canada’s entire supply of COVID-19 vaccines. When questioned about this, Trudeau said Canada’s focus is on ensuring its contracts with Pfizer and Moderna “continue to be respected” and that transparency measures “will not interfere with shipments destined for Canada.”
Canada’s vaccine supply has been cut by both Moderna and Pfizer in the past week, as the European Union promised to spare Canada from vaccine export controls.
For more info, please go to https://globalnews.ca/news/7612243/eu-vaccine-export-canada-minister/
Subscribe to Global News Channel HERE: http://bit.ly/20fcXDc
Like Global News on Facebook HERE: http://bit.ly/255GMJQ
Follow Global News on Twitter HERE: http://bit.ly/1Toz8mt
Follow Global News on Instagram HERE: https://bit.ly/2QZaZIB
#Canada #COVID19 #Coronavirus #GlobalNews #cdnpoli #trudeau #travel